Global Transthyretin (TTR) Modulators Market Growth 2026-2032
The global Transthyretin (TTR) Modulators market size is predicted to grow from US$ 9471 million in 2025 to US$ 22154 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032.
Transthyretin (TTR) Modulators are disease-modifying pharmaceutical therapies designed to interfere directly with the pathogenic process of transthyretin amyloidosis by either stabilizing the transthyretin protein or reducing its production. Transthyretin is a transport protein synthesized predominantly in the liver and normally circulates in the blood as a tetramer composed of four identical subunits. Under pathological conditions, the tetramer can become unstable and dissociate into monomers, which subsequently misfold, aggregate and form insoluble amyloid fibrils. Progressive deposition of these fibrils in tissues and organs can impair normal physiological function and lead to transthyretin amyloidosis, or ATTR amyloidosis.
ATTR amyloidosis is generally divided into wild-type transthyretin amyloidosis (ATTRwt) and hereditary or variant transthyretin amyloidosis (ATTRv/hATTR). Wild-type disease occurs without a pathogenic TTR gene mutation and predominantly affects the heart, typically presenting as transthyretin amyloid cardiomyopathy (ATTR-CM). Hereditary ATTR is caused by pathogenic variants in the TTR gene and can produce a heterogeneous clinical phenotype involving peripheral nerves, the autonomic nervous system, the heart or multiple organ systems simultaneously. The two major clinical manifestations relevant to the TTR Modulators market are therefore ATTR-CM and hereditary ATTR polyneuropathy (hATTR-PN or ATTRv-PN).
TTR Modulators act at different stages of the amyloid-forming pathway. Based on mechanism of action, they can be broadly divided into TTR Stabilizers and TTR Silencers / Suppressors.
TTR Stabilizers act directly on circulating transthyretin protein. These small-molecule therapies bind to the thyroxine-binding sites of the TTR tetramer and increase its kinetic stability, thereby reducing tetramer dissociation into amyloidogenic monomers. By preventing or slowing this early step in the amyloid cascade, stabilizers reduce the formation of misfolded TTR intermediates and subsequent amyloid deposition. Major molecules in this category include tafamidis and acoramidis. Tafamidis is commercially available in different formulations and strengths and has established an important role in ATTR-CM and, in certain markets and formulations, hATTR-PN. Acoramidis represents a newer TTR stabilizer developed to achieve strong tetramer stabilization and is used primarily in ATTR-CM.
TTR Silencers / Suppressors act further upstream by reducing the synthesis of transthyretin itself, primarily in hepatocytes. These therapies target TTR messenger RNA and decrease the production of both variant and wild-type TTR protein, thereby reducing the circulating substrate available for misfolding and amyloid formation. Two principal molecular technologies are used in currently commercialized TTR silencers: small interfering RNA (siRNA) and antisense oligonucleotides (ASOs). siRNA therapies include patisiran (ONPATTRO) and vutrisiran (AMVUTTRA), while ASO therapies include inotersen (TEGSEDI) and eplontersen (WAINUA/WAINZUA). These therapies differ in molecular design, route of administration, dosing frequency, approved indication and geographic availability, but share the common therapeutic objective of lowering circulating TTR levels.
The distinction between stabilization and silencing is clinically important. Stabilizers preserve the native tetrameric structure of TTR but do not substantially reduce total TTR production, whereas silencers lower the amount of TTR protein produced by the liver. Both approaches are intended to modify the underlying disease process rather than merely relieve symptoms. This differentiates TTR Modulators from conventional supportive therapies used to manage heart failure, neuropathic pain, arrhythmias, gastrointestinal dysfunction or other complications of ATTR amyloidosis.
The therapeutic landscape is also evolving beyond traditional chronic stabilizers and RNA-targeting medicines. New approaches under clinical development include longer-acting RNA interference technologies and in-vivo gene-editing therapies, which aim to achieve more durable suppression of hepatic TTR production after substantially fewer treatment administrations. These technologies target the same fundamental disease pathway and may eventually further broaden the concept of TTR modulation, although their clinical and commercial roles depend on successful development, regulatory approval and market access.
In summary, Transthyretin (TTR) Modulators refer to disease-modifying therapies that directly alter the stability, production or availability of transthyretin protein in order to reduce TTR misfolding, amyloid formation and progressive tissue deposition. The category currently consists primarily of TTR Stabilizers and TTR Silencers / Suppressors, with the principal therapeutic applications being ATTR-CM and hATTR-PN/ATTRv-PN. These therapies represent the core pharmacological approach to modifying the underlying pathophysiology of transthyretin amyloidosis rather than simply treating its downstream clinical symptoms.
The global Transthyretin (TTR) Modulators market is entering an important phase of expansion, moving beyond a highly specialized rare-disease treatment setting toward broader and more structured disease management. Improving awareness of ATTR amyloidosis, wider use of genetic testing and advanced cardiac imaging, and stronger collaboration among cardiologists, neurologists and rare-disease specialists are helping identify patients who were previously undiagnosed or diagnosed late. As a result, the global pool of patients eligible for disease-modifying treatment continues to expand.
From a therapeutic perspective, ATTR-CM is emerging as the primary growth engine of the global TTR Modulators market. Compared with the historically smaller hereditary polyneuropathy population, ATTR-CM encompasses a broader patient base, including both hereditary and wild-type disease. Tafamidis has established a strong treatment foundation, while newer stabilizers such as acoramidis and the expansion of RNA-silencing therapies into cardiomyopathy are creating a more diversified disease-modifying treatment landscape.
The global competitive environment is also evolving from a relatively concentrated stabilizer market toward a multi-mechanism treatment landscape encompassing TTR stabilizers, RNA interference therapies, antisense oligonucleotides and next-generation long-duration approaches. TTR stabilizers remain a core component of current treatment, while newer silencers such as AMVUTTRA and WAINUA/WAINZUA are improving competitiveness through less frequent dosing, greater convenience and broader therapeutic positioning. At the same time, emerging gene-editing and other durable technologies may further reshape the market by moving treatment toward longer-lasting TTR suppression.
Major innovative participants include Pfizer, Alnylam Pharmaceuticals, BridgeBio/Bayer, and Ionis/AstraZeneca, among others. Partnerships between large pharmaceutical companies and biotechnology companies specializing in rare diseases, RNA technologies and precision medicine are becoming increasingly important. Global regulatory capabilities, reimbursement access, specialist commercial networks and lifecycle management are likely to play an increasingly important role in determining long-term competitive positioning.
Looking ahead, the global TTR Modulators market is expected to maintain a favorable growth outlook, although the basis of competition will gradually shift from simply providing an effective disease-modifying therapy toward delivering greater clinical benefit, lower treatment burden, broader patient coverage and stronger long-term value. As additional therapies reach the market, reimbursement coverage expands and ATTR diagnosis improves worldwide, the TTR Modulators market is expected to develop into an increasingly diversified, multi-product and globally competitive specialty therapeutics market.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Transthyretin (TTR) Modulators Industry Forecast” looks at past sales and reviews total world Transthyretin (TTR) Modulators sales in 2025, providing a comprehensive analysis by region and market sector of projected Transthyretin (TTR) Modulators sales for 2026 through 2032. With Transthyretin (TTR) Modulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transthyretin (TTR) Modulators industry.
This Insight Report provides a comprehensive analysis of the global Transthyretin (TTR) Modulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transthyretin (TTR) Modulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transthyretin (TTR) Modulators market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transthyretin (TTR) Modulators and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transthyretin (TTR) Modulators.
This report presents a comprehensive overview, market shares, and growth opportunities of Transthyretin (TTR) Modulators market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Transthyretin (TTR) Modulators are disease-modifying pharmaceutical therapies designed to interfere directly with the pathogenic process of transthyretin amyloidosis by either stabilizing the transthyretin protein or reducing its production. Transthyretin is a transport protein synthesized predominantly in the liver and normally circulates in the blood as a tetramer composed of four identical subunits. Under pathological conditions, the tetramer can become unstable and dissociate into monomers, which subsequently misfold, aggregate and form insoluble amyloid fibrils. Progressive deposition of these fibrils in tissues and organs can impair normal physiological function and lead to transthyretin amyloidosis, or ATTR amyloidosis.
ATTR amyloidosis is generally divided into wild-type transthyretin amyloidosis (ATTRwt) and hereditary or variant transthyretin amyloidosis (ATTRv/hATTR). Wild-type disease occurs without a pathogenic TTR gene mutation and predominantly affects the heart, typically presenting as transthyretin amyloid cardiomyopathy (ATTR-CM). Hereditary ATTR is caused by pathogenic variants in the TTR gene and can produce a heterogeneous clinical phenotype involving peripheral nerves, the autonomic nervous system, the heart or multiple organ systems simultaneously. The two major clinical manifestations relevant to the TTR Modulators market are therefore ATTR-CM and hereditary ATTR polyneuropathy (hATTR-PN or ATTRv-PN).
TTR Modulators act at different stages of the amyloid-forming pathway. Based on mechanism of action, they can be broadly divided into TTR Stabilizers and TTR Silencers / Suppressors.
TTR Stabilizers act directly on circulating transthyretin protein. These small-molecule therapies bind to the thyroxine-binding sites of the TTR tetramer and increase its kinetic stability, thereby reducing tetramer dissociation into amyloidogenic monomers. By preventing or slowing this early step in the amyloid cascade, stabilizers reduce the formation of misfolded TTR intermediates and subsequent amyloid deposition. Major molecules in this category include tafamidis and acoramidis. Tafamidis is commercially available in different formulations and strengths and has established an important role in ATTR-CM and, in certain markets and formulations, hATTR-PN. Acoramidis represents a newer TTR stabilizer developed to achieve strong tetramer stabilization and is used primarily in ATTR-CM.
TTR Silencers / Suppressors act further upstream by reducing the synthesis of transthyretin itself, primarily in hepatocytes. These therapies target TTR messenger RNA and decrease the production of both variant and wild-type TTR protein, thereby reducing the circulating substrate available for misfolding and amyloid formation. Two principal molecular technologies are used in currently commercialized TTR silencers: small interfering RNA (siRNA) and antisense oligonucleotides (ASOs). siRNA therapies include patisiran (ONPATTRO) and vutrisiran (AMVUTTRA), while ASO therapies include inotersen (TEGSEDI) and eplontersen (WAINUA/WAINZUA). These therapies differ in molecular design, route of administration, dosing frequency, approved indication and geographic availability, but share the common therapeutic objective of lowering circulating TTR levels.
The distinction between stabilization and silencing is clinically important. Stabilizers preserve the native tetrameric structure of TTR but do not substantially reduce total TTR production, whereas silencers lower the amount of TTR protein produced by the liver. Both approaches are intended to modify the underlying disease process rather than merely relieve symptoms. This differentiates TTR Modulators from conventional supportive therapies used to manage heart failure, neuropathic pain, arrhythmias, gastrointestinal dysfunction or other complications of ATTR amyloidosis.
The therapeutic landscape is also evolving beyond traditional chronic stabilizers and RNA-targeting medicines. New approaches under clinical development include longer-acting RNA interference technologies and in-vivo gene-editing therapies, which aim to achieve more durable suppression of hepatic TTR production after substantially fewer treatment administrations. These technologies target the same fundamental disease pathway and may eventually further broaden the concept of TTR modulation, although their clinical and commercial roles depend on successful development, regulatory approval and market access.
In summary, Transthyretin (TTR) Modulators refer to disease-modifying therapies that directly alter the stability, production or availability of transthyretin protein in order to reduce TTR misfolding, amyloid formation and progressive tissue deposition. The category currently consists primarily of TTR Stabilizers and TTR Silencers / Suppressors, with the principal therapeutic applications being ATTR-CM and hATTR-PN/ATTRv-PN. These therapies represent the core pharmacological approach to modifying the underlying pathophysiology of transthyretin amyloidosis rather than simply treating its downstream clinical symptoms.
The global Transthyretin (TTR) Modulators market is entering an important phase of expansion, moving beyond a highly specialized rare-disease treatment setting toward broader and more structured disease management. Improving awareness of ATTR amyloidosis, wider use of genetic testing and advanced cardiac imaging, and stronger collaboration among cardiologists, neurologists and rare-disease specialists are helping identify patients who were previously undiagnosed or diagnosed late. As a result, the global pool of patients eligible for disease-modifying treatment continues to expand.
From a therapeutic perspective, ATTR-CM is emerging as the primary growth engine of the global TTR Modulators market. Compared with the historically smaller hereditary polyneuropathy population, ATTR-CM encompasses a broader patient base, including both hereditary and wild-type disease. Tafamidis has established a strong treatment foundation, while newer stabilizers such as acoramidis and the expansion of RNA-silencing therapies into cardiomyopathy are creating a more diversified disease-modifying treatment landscape.
The global competitive environment is also evolving from a relatively concentrated stabilizer market toward a multi-mechanism treatment landscape encompassing TTR stabilizers, RNA interference therapies, antisense oligonucleotides and next-generation long-duration approaches. TTR stabilizers remain a core component of current treatment, while newer silencers such as AMVUTTRA and WAINUA/WAINZUA are improving competitiveness through less frequent dosing, greater convenience and broader therapeutic positioning. At the same time, emerging gene-editing and other durable technologies may further reshape the market by moving treatment toward longer-lasting TTR suppression.
Major innovative participants include Pfizer, Alnylam Pharmaceuticals, BridgeBio/Bayer, and Ionis/AstraZeneca, among others. Partnerships between large pharmaceutical companies and biotechnology companies specializing in rare diseases, RNA technologies and precision medicine are becoming increasingly important. Global regulatory capabilities, reimbursement access, specialist commercial networks and lifecycle management are likely to play an increasingly important role in determining long-term competitive positioning.
Looking ahead, the global TTR Modulators market is expected to maintain a favorable growth outlook, although the basis of competition will gradually shift from simply providing an effective disease-modifying therapy toward delivering greater clinical benefit, lower treatment burden, broader patient coverage and stronger long-term value. As additional therapies reach the market, reimbursement coverage expands and ATTR diagnosis improves worldwide, the TTR Modulators market is expected to develop into an increasingly diversified, multi-product and globally competitive specialty therapeutics market.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Transthyretin (TTR) Modulators Industry Forecast” looks at past sales and reviews total world Transthyretin (TTR) Modulators sales in 2025, providing a comprehensive analysis by region and market sector of projected Transthyretin (TTR) Modulators sales for 2026 through 2032. With Transthyretin (TTR) Modulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transthyretin (TTR) Modulators industry.
This Insight Report provides a comprehensive analysis of the global Transthyretin (TTR) Modulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transthyretin (TTR) Modulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transthyretin (TTR) Modulators market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transthyretin (TTR) Modulators and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transthyretin (TTR) Modulators.
This report presents a comprehensive overview, market shares, and growth opportunities of Transthyretin (TTR) Modulators market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- TTR Stabilizers
- TTR Silencers / Suppressors
Segmentation by Administration:
- Oral TTR Modulators
- Subcutaneous/Intravenous TTR Modulators
Segmentation by Application:
- ATTR-CM
- hATTR-PN
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.
- Alnylam Pharmaceuticals, Inc.
- BridgeBio Pharma, Inc.
- Bayer AG
- AstraZeneca PLC
- Ionis Pharmaceuticals, Inc.
- PTC Therapeutics, Inc.
- Grupo Bag?
- Qilu Pharmaceutical Co., Ltd.
- Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
- Hebei Renhe Yikang Pharmaceutical Co., Ltd.
- Tuteur S.A.C.I.F.I.A.
- Monte Verde S.A.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Transthyretin (TTR) Modulators market?
- What factors are driving Transthyretin (TTR) Modulators market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Transthyretin (TTR) Modulators market opportunities vary by end market size?
- How does Transthyretin (TTR) Modulators break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transthyretin (TTR) Modulators Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Transthyretin (TTR) Modulators by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Transthyretin (TTR) Modulators by Country/Region, 2021, 2025 & 2032
2.2 Transthyretin (TTR) Modulators Segment by Type
2.2.1 TTR Stabilizers
2.2.2 TTR Silencers / Suppressors
2.2.3 Transthyretin (TTR) Modulators Sales by Type
2.2.3.1 Global Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
2.2.3.2 Global Transthyretin (TTR) Modulators Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Transthyretin (TTR) Modulators Sale Price by Type (2021-2026)
2.3 Transthyretin (TTR) Modulators Segment by Administration
2.3.1 Oral TTR Modulators
2.3.2 Subcutaneous/Intravenous TTR Modulators
2.3.3 Transthyretin (TTR) Modulators Sales by Administration
2.3.3.1 Global Transthyretin (TTR) Modulators Sales Market Share by Administration (2021-2026)
2.3.3.2 Global Transthyretin (TTR) Modulators Revenue and Market Share by Administration (2021-2026)
2.3.3.3 Global Transthyretin (TTR) Modulators Sale Price by Administration (2021-2026)
2.4 Transthyretin (TTR) Modulators Segment by Application
2.4.1 ATTR-CM
2.4.2 hATTR-PN
2.4.3 Transthyretin (TTR) Modulators Sales by Application
2.4.3.1 Global Transthyretin (TTR) Modulators Sale Market Share by Application (2021-2026)
2.4.3.2 Global Transthyretin (TTR) Modulators Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Transthyretin (TTR) Modulators Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Transthyretin (TTR) Modulators Breakdown Data by Company
3.1.1 Global Transthyretin (TTR) Modulators Annual Sales by Company (2021-2026)
3.1.2 Global Transthyretin (TTR) Modulators Sales Market Share by Company (2021-2026)
3.2 Global Transthyretin (TTR) Modulators Annual Revenue by Company (2021-2026)
3.2.1 Global Transthyretin (TTR) Modulators Revenue by Company (2021-2026)
3.2.2 Global Transthyretin (TTR) Modulators Revenue Market Share by Company (2021-2026)
3.3 Global Transthyretin (TTR) Modulators Sale Price by Company
3.4 Key Manufacturers Transthyretin (TTR) Modulators Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transthyretin (TTR) Modulators Product Location Distribution
3.4.2 Players Transthyretin (TTR) Modulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRANSTHYRETIN (TTR) MODULATORS BY GEOGRAPHIC REGION
4.1 World Historic Transthyretin (TTR) Modulators Market Size by Geographic Region (2021-2026)
4.1.1 Global Transthyretin (TTR) Modulators Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Transthyretin (TTR) Modulators Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Transthyretin (TTR) Modulators Market Size by Country/Region (2021-2026)
4.2.1 Global Transthyretin (TTR) Modulators Annual Sales by Country/Region (2021-2026)
4.2.2 Global Transthyretin (TTR) Modulators Annual Revenue by Country/Region (2021-2026)
4.3 Americas Transthyretin (TTR) Modulators Sales Growth
4.4 APAC Transthyretin (TTR) Modulators Sales Growth
4.5 Europe Transthyretin (TTR) Modulators Sales Growth
4.6 Middle East & Africa Transthyretin (TTR) Modulators Sales Growth
5 AMERICAS
5.1 Americas Transthyretin (TTR) Modulators Sales by Country
5.1.1 Americas Transthyretin (TTR) Modulators Sales by Country (2021-2026)
5.1.2 Americas Transthyretin (TTR) Modulators Revenue by Country (2021-2026)
5.2 Americas Transthyretin (TTR) Modulators Sales by Type (2021-2026)
5.3 Americas Transthyretin (TTR) Modulators Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transthyretin (TTR) Modulators Sales by Region
6.1.1 APAC Transthyretin (TTR) Modulators Sales by Region (2021-2026)
6.1.2 APAC Transthyretin (TTR) Modulators Revenue by Region (2021-2026)
6.2 APAC Transthyretin (TTR) Modulators Sales by Type (2021-2026)
6.3 APAC Transthyretin (TTR) Modulators Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Transthyretin (TTR) Modulators by Country
7.1.1 Europe Transthyretin (TTR) Modulators Sales by Country (2021-2026)
7.1.2 Europe Transthyretin (TTR) Modulators Revenue by Country (2021-2026)
7.2 Europe Transthyretin (TTR) Modulators Sales by Type (2021-2026)
7.3 Europe Transthyretin (TTR) Modulators Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transthyretin (TTR) Modulators by Country
8.1.1 Middle East & Africa Transthyretin (TTR) Modulators Sales by Country (2021-2026)
8.1.2 Middle East & Africa Transthyretin (TTR) Modulators Revenue by Country (2021-2026)
8.2 Middle East & Africa Transthyretin (TTR) Modulators Sales by Type (2021-2026)
8.3 Middle East & Africa Transthyretin (TTR) Modulators Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transthyretin (TTR) Modulators
10.3 Manufacturing Process Analysis of Transthyretin (TTR) Modulators
10.4 Industry Chain Structure of Transthyretin (TTR) Modulators
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transthyretin (TTR) Modulators Distributors
11.3 Transthyretin (TTR) Modulators Customer
12 WORLD FORECAST REVIEW FOR TRANSTHYRETIN (TTR) MODULATORS BY GEOGRAPHIC REGION
12.1 Global Transthyretin (TTR) Modulators Market Size Forecast by Region
12.1.1 Global Transthyretin (TTR) Modulators Forecast by Region (2027-2032)
12.1.2 Global Transthyretin (TTR) Modulators Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Transthyretin (TTR) Modulators Forecast by Type (2027-2032)
12.7 Global Transthyretin (TTR) Modulators Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.1.3 Pfizer Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 Alnylam Pharmaceuticals, Inc.
13.2.1 Alnylam Pharmaceuticals, Inc. Company Information
13.2.2 Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.2.3 Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Alnylam Pharmaceuticals, Inc. Main Business Overview
13.2.5 Alnylam Pharmaceuticals, Inc. Latest Developments
13.3 BridgeBio Pharma, Inc.
13.3.1 BridgeBio Pharma, Inc. Company Information
13.3.2 BridgeBio Pharma, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.3.3 BridgeBio Pharma, Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BridgeBio Pharma, Inc. Main Business Overview
13.3.5 BridgeBio Pharma, Inc. Latest Developments
13.4 Bayer AG
13.4.1 Bayer AG Company Information
13.4.2 Bayer AG Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.4.3 Bayer AG Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bayer AG Main Business Overview
13.4.5 Bayer AG Latest Developments
13.5 AstraZeneca PLC
13.5.1 AstraZeneca PLC Company Information
13.5.2 AstraZeneca PLC Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.5.3 AstraZeneca PLC Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 AstraZeneca PLC Main Business Overview
13.5.5 AstraZeneca PLC Latest Developments
13.6 Ionis Pharmaceuticals, Inc.
13.6.1 Ionis Pharmaceuticals, Inc. Company Information
13.6.2 Ionis Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.6.3 Ionis Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ionis Pharmaceuticals, Inc. Main Business Overview
13.6.5 Ionis Pharmaceuticals, Inc. Latest Developments
13.7 PTC Therapeutics, Inc.
13.7.1 PTC Therapeutics, Inc. Company Information
13.7.2 PTC Therapeutics, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.7.3 PTC Therapeutics, Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 PTC Therapeutics, Inc. Main Business Overview
13.7.5 PTC Therapeutics, Inc. Latest Developments
13.8 Grupo Bag?
13.8.1 Grupo Bag? Company Information
13.8.2 Grupo Bag? Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.8.3 Grupo Bag? Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Grupo Bag? Main Business Overview
13.8.5 Grupo Bag? Latest Developments
13.9 Qilu Pharmaceutical Co., Ltd.
13.9.1 Qilu Pharmaceutical Co., Ltd. Company Information
13.9.2 Qilu Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.9.3 Qilu Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Qilu Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Qilu Pharmaceutical Co., Ltd. Latest Developments
13.10 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
13.10.1 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Company Information
13.10.2 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.10.3 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Latest Developments
13.11 Hebei Renhe Yikang Pharmaceutical Co., Ltd.
13.11.1 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Company Information
13.11.2 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.11.3 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Latest Developments
13.12 Tuteur S.A.C.I.F.I.A.
13.12.1 Tuteur S.A.C.I.F.I.A. Company Information
13.12.2 Tuteur S.A.C.I.F.I.A. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.12.3 Tuteur S.A.C.I.F.I.A. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tuteur S.A.C.I.F.I.A. Main Business Overview
13.12.5 Tuteur S.A.C.I.F.I.A. Latest Developments
13.13 Monte Verde S.A.
13.13.1 Monte Verde S.A. Company Information
13.13.2 Monte Verde S.A. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.13.3 Monte Verde S.A. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Monte Verde S.A. Main Business Overview
13.13.5 Monte Verde S.A. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transthyretin (TTR) Modulators Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Transthyretin (TTR) Modulators by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Transthyretin (TTR) Modulators by Country/Region, 2021, 2025 & 2032
2.2 Transthyretin (TTR) Modulators Segment by Type
2.2.1 TTR Stabilizers
2.2.2 TTR Silencers / Suppressors
2.2.3 Transthyretin (TTR) Modulators Sales by Type
2.2.3.1 Global Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
2.2.3.2 Global Transthyretin (TTR) Modulators Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Transthyretin (TTR) Modulators Sale Price by Type (2021-2026)
2.3 Transthyretin (TTR) Modulators Segment by Administration
2.3.1 Oral TTR Modulators
2.3.2 Subcutaneous/Intravenous TTR Modulators
2.3.3 Transthyretin (TTR) Modulators Sales by Administration
2.3.3.1 Global Transthyretin (TTR) Modulators Sales Market Share by Administration (2021-2026)
2.3.3.2 Global Transthyretin (TTR) Modulators Revenue and Market Share by Administration (2021-2026)
2.3.3.3 Global Transthyretin (TTR) Modulators Sale Price by Administration (2021-2026)
2.4 Transthyretin (TTR) Modulators Segment by Application
2.4.1 ATTR-CM
2.4.2 hATTR-PN
2.4.3 Transthyretin (TTR) Modulators Sales by Application
2.4.3.1 Global Transthyretin (TTR) Modulators Sale Market Share by Application (2021-2026)
2.4.3.2 Global Transthyretin (TTR) Modulators Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Transthyretin (TTR) Modulators Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Transthyretin (TTR) Modulators Breakdown Data by Company
3.1.1 Global Transthyretin (TTR) Modulators Annual Sales by Company (2021-2026)
3.1.2 Global Transthyretin (TTR) Modulators Sales Market Share by Company (2021-2026)
3.2 Global Transthyretin (TTR) Modulators Annual Revenue by Company (2021-2026)
3.2.1 Global Transthyretin (TTR) Modulators Revenue by Company (2021-2026)
3.2.2 Global Transthyretin (TTR) Modulators Revenue Market Share by Company (2021-2026)
3.3 Global Transthyretin (TTR) Modulators Sale Price by Company
3.4 Key Manufacturers Transthyretin (TTR) Modulators Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transthyretin (TTR) Modulators Product Location Distribution
3.4.2 Players Transthyretin (TTR) Modulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRANSTHYRETIN (TTR) MODULATORS BY GEOGRAPHIC REGION
4.1 World Historic Transthyretin (TTR) Modulators Market Size by Geographic Region (2021-2026)
4.1.1 Global Transthyretin (TTR) Modulators Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Transthyretin (TTR) Modulators Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Transthyretin (TTR) Modulators Market Size by Country/Region (2021-2026)
4.2.1 Global Transthyretin (TTR) Modulators Annual Sales by Country/Region (2021-2026)
4.2.2 Global Transthyretin (TTR) Modulators Annual Revenue by Country/Region (2021-2026)
4.3 Americas Transthyretin (TTR) Modulators Sales Growth
4.4 APAC Transthyretin (TTR) Modulators Sales Growth
4.5 Europe Transthyretin (TTR) Modulators Sales Growth
4.6 Middle East & Africa Transthyretin (TTR) Modulators Sales Growth
5 AMERICAS
5.1 Americas Transthyretin (TTR) Modulators Sales by Country
5.1.1 Americas Transthyretin (TTR) Modulators Sales by Country (2021-2026)
5.1.2 Americas Transthyretin (TTR) Modulators Revenue by Country (2021-2026)
5.2 Americas Transthyretin (TTR) Modulators Sales by Type (2021-2026)
5.3 Americas Transthyretin (TTR) Modulators Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transthyretin (TTR) Modulators Sales by Region
6.1.1 APAC Transthyretin (TTR) Modulators Sales by Region (2021-2026)
6.1.2 APAC Transthyretin (TTR) Modulators Revenue by Region (2021-2026)
6.2 APAC Transthyretin (TTR) Modulators Sales by Type (2021-2026)
6.3 APAC Transthyretin (TTR) Modulators Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Transthyretin (TTR) Modulators by Country
7.1.1 Europe Transthyretin (TTR) Modulators Sales by Country (2021-2026)
7.1.2 Europe Transthyretin (TTR) Modulators Revenue by Country (2021-2026)
7.2 Europe Transthyretin (TTR) Modulators Sales by Type (2021-2026)
7.3 Europe Transthyretin (TTR) Modulators Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transthyretin (TTR) Modulators by Country
8.1.1 Middle East & Africa Transthyretin (TTR) Modulators Sales by Country (2021-2026)
8.1.2 Middle East & Africa Transthyretin (TTR) Modulators Revenue by Country (2021-2026)
8.2 Middle East & Africa Transthyretin (TTR) Modulators Sales by Type (2021-2026)
8.3 Middle East & Africa Transthyretin (TTR) Modulators Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transthyretin (TTR) Modulators
10.3 Manufacturing Process Analysis of Transthyretin (TTR) Modulators
10.4 Industry Chain Structure of Transthyretin (TTR) Modulators
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transthyretin (TTR) Modulators Distributors
11.3 Transthyretin (TTR) Modulators Customer
12 WORLD FORECAST REVIEW FOR TRANSTHYRETIN (TTR) MODULATORS BY GEOGRAPHIC REGION
12.1 Global Transthyretin (TTR) Modulators Market Size Forecast by Region
12.1.1 Global Transthyretin (TTR) Modulators Forecast by Region (2027-2032)
12.1.2 Global Transthyretin (TTR) Modulators Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Transthyretin (TTR) Modulators Forecast by Type (2027-2032)
12.7 Global Transthyretin (TTR) Modulators Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.1.3 Pfizer Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 Alnylam Pharmaceuticals, Inc.
13.2.1 Alnylam Pharmaceuticals, Inc. Company Information
13.2.2 Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.2.3 Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Alnylam Pharmaceuticals, Inc. Main Business Overview
13.2.5 Alnylam Pharmaceuticals, Inc. Latest Developments
13.3 BridgeBio Pharma, Inc.
13.3.1 BridgeBio Pharma, Inc. Company Information
13.3.2 BridgeBio Pharma, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.3.3 BridgeBio Pharma, Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BridgeBio Pharma, Inc. Main Business Overview
13.3.5 BridgeBio Pharma, Inc. Latest Developments
13.4 Bayer AG
13.4.1 Bayer AG Company Information
13.4.2 Bayer AG Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.4.3 Bayer AG Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bayer AG Main Business Overview
13.4.5 Bayer AG Latest Developments
13.5 AstraZeneca PLC
13.5.1 AstraZeneca PLC Company Information
13.5.2 AstraZeneca PLC Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.5.3 AstraZeneca PLC Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 AstraZeneca PLC Main Business Overview
13.5.5 AstraZeneca PLC Latest Developments
13.6 Ionis Pharmaceuticals, Inc.
13.6.1 Ionis Pharmaceuticals, Inc. Company Information
13.6.2 Ionis Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.6.3 Ionis Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ionis Pharmaceuticals, Inc. Main Business Overview
13.6.5 Ionis Pharmaceuticals, Inc. Latest Developments
13.7 PTC Therapeutics, Inc.
13.7.1 PTC Therapeutics, Inc. Company Information
13.7.2 PTC Therapeutics, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.7.3 PTC Therapeutics, Inc. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 PTC Therapeutics, Inc. Main Business Overview
13.7.5 PTC Therapeutics, Inc. Latest Developments
13.8 Grupo Bag?
13.8.1 Grupo Bag? Company Information
13.8.2 Grupo Bag? Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.8.3 Grupo Bag? Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Grupo Bag? Main Business Overview
13.8.5 Grupo Bag? Latest Developments
13.9 Qilu Pharmaceutical Co., Ltd.
13.9.1 Qilu Pharmaceutical Co., Ltd. Company Information
13.9.2 Qilu Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.9.3 Qilu Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Qilu Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Qilu Pharmaceutical Co., Ltd. Latest Developments
13.10 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
13.10.1 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Company Information
13.10.2 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.10.3 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Latest Developments
13.11 Hebei Renhe Yikang Pharmaceutical Co., Ltd.
13.11.1 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Company Information
13.11.2 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.11.3 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Hebei Renhe Yikang Pharmaceutical Co., Ltd. Latest Developments
13.12 Tuteur S.A.C.I.F.I.A.
13.12.1 Tuteur S.A.C.I.F.I.A. Company Information
13.12.2 Tuteur S.A.C.I.F.I.A. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.12.3 Tuteur S.A.C.I.F.I.A. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tuteur S.A.C.I.F.I.A. Main Business Overview
13.12.5 Tuteur S.A.C.I.F.I.A. Latest Developments
13.13 Monte Verde S.A.
13.13.1 Monte Verde S.A. Company Information
13.13.2 Monte Verde S.A. Transthyretin (TTR) Modulators Product Portfolios and Specifications
13.13.3 Monte Verde S.A. Transthyretin (TTR) Modulators Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Monte Verde S.A. Main Business Overview
13.13.5 Monte Verde S.A. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Transthyretin (TTR) Modulators Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Transthyretin (TTR) Modulators Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of TTR Stabilizers
Table 4. Major Players of TTR Silencers / Suppressors
Table 5. Global Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 6. Global Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Table 7. Global Transthyretin (TTR) Modulators Revenue by Type (2021-2026) & ($ million)
Table 8. Global Transthyretin (TTR) Modulators Revenue Market Share by Type (2021-2026)
Table 9. Global Transthyretin (TTR) Modulators Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Oral TTR Modulators
Table 11. Major Players of Subcutaneous/Intravenous TTR Modulators
Table 12. Global Transthyretin (TTR) Modulators Sales by Administration (2021-2026) & (K Units)
Table 13. Global Transthyretin (TTR) Modulators Sales Market Share by Administration (2021-2026)
Table 14. Global Transthyretin (TTR) Modulators Revenue by Administration (2021-2026) & ($ million)
Table 15. Global Transthyretin (TTR) Modulators Revenue Market Share by Administration (2021-2026)
Table 16. Global Transthyretin (TTR) Modulators Sale Price by Administration (2021-2026) & (US$/Unit)
Table 17. Global Transthyretin (TTR) Modulators Sale by Application (2021-2026) & (K Units)
Table 18. Global Transthyretin (TTR) Modulators Sale Market Share by Application (2021-2026)
Table 19. Global Transthyretin (TTR) Modulators Revenue by Application (2021-2026) & ($ million)
Table 20. Global Transthyretin (TTR) Modulators Revenue Market Share by Application (2021-2026)
Table 21. Global Transthyretin (TTR) Modulators Sale Price by Application (2021-2026) & (US$/Unit)
Table 22. Global Transthyretin (TTR) Modulators Sales by Company (2021-2026) & (K Units)
Table 23. Global Transthyretin (TTR) Modulators Sales Market Share by Company (2021-2026)
Table 24. Global Transthyretin (TTR) Modulators Revenue by Company (2021-2026) & ($ millions)
Table 25. Global Transthyretin (TTR) Modulators Revenue Market Share by Company (2021-2026)
Table 26. Global Transthyretin (TTR) Modulators Sale Price by Company (2021-2026) & (US$/Unit)
Table 27. Key Manufacturers Transthyretin (TTR) Modulators Producing Area Distribution and Sales Area
Table 28. Players Transthyretin (TTR) Modulators Products Offered
Table 29. Transthyretin (TTR) Modulators Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Market M&A Activity & Strategy
Table 32. Global Transthyretin (TTR) Modulators Sales by Geographic Region (2021-2026) & (K Units)
Table 33. Global Transthyretin (TTR) Modulators Sales Market Share Geographic Region (2021-2026)
Table 34. Global Transthyretin (TTR) Modulators Revenue by Geographic Region (2021-2026) & ($ millions)
Table 35. Global Transthyretin (TTR) Modulators Revenue Market Share by Geographic Region (2021-2026)
Table 36. Global Transthyretin (TTR) Modulators Sales by Country/Region (2021-2026) & (K Units)
Table 37. Global Transthyretin (TTR) Modulators Sales Market Share by Country/Region (2021-2026)
Table 38. Global Transthyretin (TTR) Modulators Revenue by Country/Region (2021-2026) & ($ millions)
Table 39. Global Transthyretin (TTR) Modulators Revenue Market Share by Country/Region (2021-2026)
Table 40. Americas Transthyretin (TTR) Modulators Sales by Country (2021-2026) & (K Units)
Table 41. Americas Transthyretin (TTR) Modulators Sales Market Share by Country (2021-2026)
Table 42. Americas Transthyretin (TTR) Modulators Revenue by Country (2021-2026) & ($ millions)
Table 43. Americas Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 44. Americas Transthyretin (TTR) Modulators Sales by Application (2021-2026) & (K Units)
Table 45. APAC Transthyretin (TTR) Modulators Sales by Region (2021-2026) & (K Units)
Table 46. APAC Transthyretin (TTR) Modulators Sales Market Share by Region (2021-2026)
Table 47. APAC Transthyretin (TTR) Modulators Revenue by Region (2021-2026) & ($ millions)
Table 48. APAC Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 49. APAC Transthyretin (TTR) Modulators Sales by Application (2021-2026) & (K Units)
Table 50. Europe Transthyretin (TTR) Modulators Sales by Country (2021-2026) & (K Units)
Table 51. Europe Transthyretin (TTR) Modulators Revenue by Country (2021-2026) & ($ millions)
Table 52. Europe Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 53. Europe Transthyretin (TTR) Modulators Sales by Application (2021-2026) & (K Units)
Table 54. Middle East & Africa Transthyretin (TTR) Modulators Sales by Country (2021-2026) & (K Units)
Table 55. Middle East & Africa Transthyretin (TTR) Modulators Revenue Market Share by Country (2021-2026)
Table 56. Middle East & Africa Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 57. Middle East & Africa Transthyretin (TTR) Modulators Sales by Application (2021-2026) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Transthyretin (TTR) Modulators
Table 59. Key Market Challenges & Risks of Transthyretin (TTR) Modulators
Table 60. Key Industry Trends of Transthyretin (TTR) Modulators
Table 61. Transthyretin (TTR) Modulators Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Transthyretin (TTR) Modulators Distributors List
Table 64. Transthyretin (TTR) Modulators Customer List
Table 65. Global Transthyretin (TTR) Modulators Sales Forecast by Region (2027-2032) & (K Units)
Table 66. Global Transthyretin (TTR) Modulators Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Americas Transthyretin (TTR) Modulators Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Americas Transthyretin (TTR) Modulators Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. APAC Transthyretin (TTR) Modulators Sales Forecast by Region (2027-2032) & (K Units)
Table 70. APAC Transthyretin (TTR) Modulators Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Europe Transthyretin (TTR) Modulators Sales Forecast by Country (2027-2032) & (K Units)
Table 72. Europe Transthyretin (TTR) Modulators Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. Middle East & Africa Transthyretin (TTR) Modulators Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Middle East & Africa Transthyretin (TTR) Modulators Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Global Transthyretin (TTR) Modulators Sales Forecast by Type (2027-2032) & (K Units)
Table 76. Global Transthyretin (TTR) Modulators Revenue Forecast by Type (2027-2032) & ($ millions)
Table 77. Global Transthyretin (TTR) Modulators Sales Forecast by Application (2027-2032) & (K Units)
Table 78. Global Transthyretin (TTR) Modulators Revenue Forecast by Application (2027-2032) & ($ millions)
Table 79. Pfizer Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 81. Pfizer Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Pfizer Inc. Main Business
Table 83. Pfizer Inc. Latest Developments
Table 84. Alnylam Pharmaceuticals, Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 85. Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 86. Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Alnylam Pharmaceuticals, Inc. Main Business
Table 88. Alnylam Pharmaceuticals, Inc. Latest Developments
Table 89. BridgeBio Pharma, Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 90. BridgeBio Pharma, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 91. BridgeBio Pharma, Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. BridgeBio Pharma, Inc. Main Business
Table 93. BridgeBio Pharma, Inc. Latest Developments
Table 94. Bayer AG Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer AG Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 96. Bayer AG Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Bayer AG Main Business
Table 98. Bayer AG Latest Developments
Table 99. AstraZeneca PLC Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca PLC Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 101. AstraZeneca PLC Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. AstraZeneca PLC Main Business
Table 103. AstraZeneca PLC Latest Developments
Table 104. Ionis Pharmaceuticals, Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 105. Ionis Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 106. Ionis Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Ionis Pharmaceuticals, Inc. Main Business
Table 108. Ionis Pharmaceuticals, Inc. Latest Developments
Table 109. PTC Therapeutics, Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 110. PTC Therapeutics, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 111. PTC Therapeutics, Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. PTC Therapeutics, Inc. Main Business
Table 113. PTC Therapeutics, Inc. Latest Developments
Table 114. Grupo Bag? Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 115. Grupo Bag? Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 116. Grupo Bag? Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Grupo Bag? Main Business
Table 118. Grupo Bag? Latest Developments
Table 119. Qilu Pharmaceutical Co., Ltd. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 120. Qilu Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 121. Qilu Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Qilu Pharmaceutical Co., Ltd. Main Business
Table 123. Qilu Pharmaceutical Co., Ltd. Latest Developments
Table 124. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 125. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 126. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Main Business
Table 128. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Latest Developments
Table 129. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 130. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 131. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Main Business
Table 133. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Latest Developments
Table 134. Tuteur S.A.C.I.F.I.A. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 135. Tuteur S.A.C.I.F.I.A. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 136. Tuteur S.A.C.I.F.I.A. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Tuteur S.A.C.I.F.I.A. Main Business
Table 138. Tuteur S.A.C.I.F.I.A. Latest Developments
Table 139. Monte Verde S.A. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 140. Monte Verde S.A. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 141. Monte Verde S.A. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Monte Verde S.A. Main Business
Table 143. Monte Verde S.A. Latest Developments
Table 1. Transthyretin (TTR) Modulators Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Transthyretin (TTR) Modulators Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of TTR Stabilizers
Table 4. Major Players of TTR Silencers / Suppressors
Table 5. Global Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 6. Global Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Table 7. Global Transthyretin (TTR) Modulators Revenue by Type (2021-2026) & ($ million)
Table 8. Global Transthyretin (TTR) Modulators Revenue Market Share by Type (2021-2026)
Table 9. Global Transthyretin (TTR) Modulators Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Oral TTR Modulators
Table 11. Major Players of Subcutaneous/Intravenous TTR Modulators
Table 12. Global Transthyretin (TTR) Modulators Sales by Administration (2021-2026) & (K Units)
Table 13. Global Transthyretin (TTR) Modulators Sales Market Share by Administration (2021-2026)
Table 14. Global Transthyretin (TTR) Modulators Revenue by Administration (2021-2026) & ($ million)
Table 15. Global Transthyretin (TTR) Modulators Revenue Market Share by Administration (2021-2026)
Table 16. Global Transthyretin (TTR) Modulators Sale Price by Administration (2021-2026) & (US$/Unit)
Table 17. Global Transthyretin (TTR) Modulators Sale by Application (2021-2026) & (K Units)
Table 18. Global Transthyretin (TTR) Modulators Sale Market Share by Application (2021-2026)
Table 19. Global Transthyretin (TTR) Modulators Revenue by Application (2021-2026) & ($ million)
Table 20. Global Transthyretin (TTR) Modulators Revenue Market Share by Application (2021-2026)
Table 21. Global Transthyretin (TTR) Modulators Sale Price by Application (2021-2026) & (US$/Unit)
Table 22. Global Transthyretin (TTR) Modulators Sales by Company (2021-2026) & (K Units)
Table 23. Global Transthyretin (TTR) Modulators Sales Market Share by Company (2021-2026)
Table 24. Global Transthyretin (TTR) Modulators Revenue by Company (2021-2026) & ($ millions)
Table 25. Global Transthyretin (TTR) Modulators Revenue Market Share by Company (2021-2026)
Table 26. Global Transthyretin (TTR) Modulators Sale Price by Company (2021-2026) & (US$/Unit)
Table 27. Key Manufacturers Transthyretin (TTR) Modulators Producing Area Distribution and Sales Area
Table 28. Players Transthyretin (TTR) Modulators Products Offered
Table 29. Transthyretin (TTR) Modulators Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Market M&A Activity & Strategy
Table 32. Global Transthyretin (TTR) Modulators Sales by Geographic Region (2021-2026) & (K Units)
Table 33. Global Transthyretin (TTR) Modulators Sales Market Share Geographic Region (2021-2026)
Table 34. Global Transthyretin (TTR) Modulators Revenue by Geographic Region (2021-2026) & ($ millions)
Table 35. Global Transthyretin (TTR) Modulators Revenue Market Share by Geographic Region (2021-2026)
Table 36. Global Transthyretin (TTR) Modulators Sales by Country/Region (2021-2026) & (K Units)
Table 37. Global Transthyretin (TTR) Modulators Sales Market Share by Country/Region (2021-2026)
Table 38. Global Transthyretin (TTR) Modulators Revenue by Country/Region (2021-2026) & ($ millions)
Table 39. Global Transthyretin (TTR) Modulators Revenue Market Share by Country/Region (2021-2026)
Table 40. Americas Transthyretin (TTR) Modulators Sales by Country (2021-2026) & (K Units)
Table 41. Americas Transthyretin (TTR) Modulators Sales Market Share by Country (2021-2026)
Table 42. Americas Transthyretin (TTR) Modulators Revenue by Country (2021-2026) & ($ millions)
Table 43. Americas Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 44. Americas Transthyretin (TTR) Modulators Sales by Application (2021-2026) & (K Units)
Table 45. APAC Transthyretin (TTR) Modulators Sales by Region (2021-2026) & (K Units)
Table 46. APAC Transthyretin (TTR) Modulators Sales Market Share by Region (2021-2026)
Table 47. APAC Transthyretin (TTR) Modulators Revenue by Region (2021-2026) & ($ millions)
Table 48. APAC Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 49. APAC Transthyretin (TTR) Modulators Sales by Application (2021-2026) & (K Units)
Table 50. Europe Transthyretin (TTR) Modulators Sales by Country (2021-2026) & (K Units)
Table 51. Europe Transthyretin (TTR) Modulators Revenue by Country (2021-2026) & ($ millions)
Table 52. Europe Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 53. Europe Transthyretin (TTR) Modulators Sales by Application (2021-2026) & (K Units)
Table 54. Middle East & Africa Transthyretin (TTR) Modulators Sales by Country (2021-2026) & (K Units)
Table 55. Middle East & Africa Transthyretin (TTR) Modulators Revenue Market Share by Country (2021-2026)
Table 56. Middle East & Africa Transthyretin (TTR) Modulators Sales by Type (2021-2026) & (K Units)
Table 57. Middle East & Africa Transthyretin (TTR) Modulators Sales by Application (2021-2026) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Transthyretin (TTR) Modulators
Table 59. Key Market Challenges & Risks of Transthyretin (TTR) Modulators
Table 60. Key Industry Trends of Transthyretin (TTR) Modulators
Table 61. Transthyretin (TTR) Modulators Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Transthyretin (TTR) Modulators Distributors List
Table 64. Transthyretin (TTR) Modulators Customer List
Table 65. Global Transthyretin (TTR) Modulators Sales Forecast by Region (2027-2032) & (K Units)
Table 66. Global Transthyretin (TTR) Modulators Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Americas Transthyretin (TTR) Modulators Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Americas Transthyretin (TTR) Modulators Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. APAC Transthyretin (TTR) Modulators Sales Forecast by Region (2027-2032) & (K Units)
Table 70. APAC Transthyretin (TTR) Modulators Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Europe Transthyretin (TTR) Modulators Sales Forecast by Country (2027-2032) & (K Units)
Table 72. Europe Transthyretin (TTR) Modulators Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. Middle East & Africa Transthyretin (TTR) Modulators Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Middle East & Africa Transthyretin (TTR) Modulators Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Global Transthyretin (TTR) Modulators Sales Forecast by Type (2027-2032) & (K Units)
Table 76. Global Transthyretin (TTR) Modulators Revenue Forecast by Type (2027-2032) & ($ millions)
Table 77. Global Transthyretin (TTR) Modulators Sales Forecast by Application (2027-2032) & (K Units)
Table 78. Global Transthyretin (TTR) Modulators Revenue Forecast by Application (2027-2032) & ($ millions)
Table 79. Pfizer Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 81. Pfizer Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Pfizer Inc. Main Business
Table 83. Pfizer Inc. Latest Developments
Table 84. Alnylam Pharmaceuticals, Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 85. Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 86. Alnylam Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Alnylam Pharmaceuticals, Inc. Main Business
Table 88. Alnylam Pharmaceuticals, Inc. Latest Developments
Table 89. BridgeBio Pharma, Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 90. BridgeBio Pharma, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 91. BridgeBio Pharma, Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. BridgeBio Pharma, Inc. Main Business
Table 93. BridgeBio Pharma, Inc. Latest Developments
Table 94. Bayer AG Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer AG Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 96. Bayer AG Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Bayer AG Main Business
Table 98. Bayer AG Latest Developments
Table 99. AstraZeneca PLC Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca PLC Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 101. AstraZeneca PLC Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. AstraZeneca PLC Main Business
Table 103. AstraZeneca PLC Latest Developments
Table 104. Ionis Pharmaceuticals, Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 105. Ionis Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 106. Ionis Pharmaceuticals, Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Ionis Pharmaceuticals, Inc. Main Business
Table 108. Ionis Pharmaceuticals, Inc. Latest Developments
Table 109. PTC Therapeutics, Inc. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 110. PTC Therapeutics, Inc. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 111. PTC Therapeutics, Inc. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. PTC Therapeutics, Inc. Main Business
Table 113. PTC Therapeutics, Inc. Latest Developments
Table 114. Grupo Bag? Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 115. Grupo Bag? Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 116. Grupo Bag? Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Grupo Bag? Main Business
Table 118. Grupo Bag? Latest Developments
Table 119. Qilu Pharmaceutical Co., Ltd. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 120. Qilu Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 121. Qilu Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Qilu Pharmaceutical Co., Ltd. Main Business
Table 123. Qilu Pharmaceutical Co., Ltd. Latest Developments
Table 124. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 125. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 126. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Main Business
Table 128. Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Latest Developments
Table 129. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 130. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 131. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Main Business
Table 133. Hebei Renhe Yikang Pharmaceutical Co., Ltd. Latest Developments
Table 134. Tuteur S.A.C.I.F.I.A. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 135. Tuteur S.A.C.I.F.I.A. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 136. Tuteur S.A.C.I.F.I.A. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Tuteur S.A.C.I.F.I.A. Main Business
Table 138. Tuteur S.A.C.I.F.I.A. Latest Developments
Table 139. Monte Verde S.A. Basic Information, Transthyretin (TTR) Modulators Manufacturing Base, Sales Area and Its Competitors
Table 140. Monte Verde S.A. Transthyretin (TTR) Modulators Product Portfolios and Specifications
Table 141. Monte Verde S.A. Transthyretin (TTR) Modulators Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Monte Verde S.A. Main Business
Table 143. Monte Verde S.A. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Transthyretin (TTR) Modulators
Figure 2. Transthyretin (TTR) Modulators Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transthyretin (TTR) Modulators Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Transthyretin (TTR) Modulators Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Transthyretin (TTR) Modulators Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Transthyretin (TTR) Modulators Sales Market Share by Country/Region (2025)
Figure 10. Transthyretin (TTR) Modulators Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of TTR Stabilizers
Figure 12. Product Picture of TTR Silencers / Suppressors
Figure 13. Global Transthyretin (TTR) Modulators Sales Market Share by Type in 2026
Figure 14. Global Transthyretin (TTR) Modulators Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Oral TTR Modulators
Figure 16. Product Picture of Subcutaneous/Intravenous TTR Modulators
Figure 17. Global Transthyretin (TTR) Modulators Sales Market Share by Administration in 2026
Figure 18. Global Transthyretin (TTR) Modulators Revenue Market Share by Administration (2021-2026)
Figure 19. Transthyretin (TTR) Modulators Consumed in ATTR-CM
Figure 20. Global Transthyretin (TTR) Modulators Market: ATTR-CM (2021-2026) & (K Units)
Figure 21. Transthyretin (TTR) Modulators Consumed in hATTR-PN
Figure 22. Global Transthyretin (TTR) Modulators Market: hATTR-PN (2021-2026) & (K Units)
Figure 23. Global Transthyretin (TTR) Modulators Sale Market Share by Application (2025)
Figure 24. Global Transthyretin (TTR) Modulators Revenue Market Share by Application in 2025
Figure 25. Transthyretin (TTR) Modulators Sales by Company in 2025 (K Units)
Figure 26. Global Transthyretin (TTR) Modulators Sales Market Share by Company in 2025
Figure 27. Transthyretin (TTR) Modulators Revenue by Company in 2025 ($ millions)
Figure 28. Global Transthyretin (TTR) Modulators Revenue Market Share by Company in 2025
Figure 29. Global Transthyretin (TTR) Modulators Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Transthyretin (TTR) Modulators Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Transthyretin (TTR) Modulators Sales 2021-2026 (K Units)
Figure 32. Americas Transthyretin (TTR) Modulators Revenue 2021-2026 ($ millions)
Figure 33. APAC Transthyretin (TTR) Modulators Sales 2021-2026 (K Units)
Figure 34. APAC Transthyretin (TTR) Modulators Revenue 2021-2026 ($ millions)
Figure 35. Europe Transthyretin (TTR) Modulators Sales 2021-2026 (K Units)
Figure 36. Europe Transthyretin (TTR) Modulators Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Transthyretin (TTR) Modulators Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Transthyretin (TTR) Modulators Revenue 2021-2026 ($ millions)
Figure 39. Americas Transthyretin (TTR) Modulators Sales Market Share by Country in 2025
Figure 40. Americas Transthyretin (TTR) Modulators Revenue Market Share by Country (2021-2026)
Figure 41. Americas Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Figure 42. Americas Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2026)
Figure 43. United States Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Transthyretin (TTR) Modulators Sales Market Share by Region in 2025
Figure 48. APAC Transthyretin (TTR) Modulators Revenue Market Share by Region (2021-2026)
Figure 49. APAC Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Figure 50. APAC Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2026)
Figure 51. China Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 55. India Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Transthyretin (TTR) Modulators Sales Market Share by Country in 2025
Figure 59. Europe Transthyretin (TTR) Modulators Revenue Market Share by Country (2021-2026)
Figure 60. Europe Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Figure 61. Europe Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2026)
Figure 62. Germany Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 63. France Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Transthyretin (TTR) Modulators Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2026)
Figure 70. Egypt Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Transthyretin (TTR) Modulators in 2026
Figure 76. Manufacturing Process Analysis of Transthyretin (TTR) Modulators
Figure 77. Industry Chain Structure of Transthyretin (TTR) Modulators
Figure 78. Channels of Distribution
Figure 79. Global Transthyretin (TTR) Modulators Sales Market Forecast by Region (2027-2032)
Figure 80. Global Transthyretin (TTR) Modulators Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Transthyretin (TTR) Modulators Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Transthyretin (TTR) Modulators Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Transthyretin (TTR) Modulators Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Transthyretin (TTR) Modulators Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Transthyretin (TTR) Modulators
Figure 2. Transthyretin (TTR) Modulators Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transthyretin (TTR) Modulators Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Transthyretin (TTR) Modulators Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Transthyretin (TTR) Modulators Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Transthyretin (TTR) Modulators Sales Market Share by Country/Region (2025)
Figure 10. Transthyretin (TTR) Modulators Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of TTR Stabilizers
Figure 12. Product Picture of TTR Silencers / Suppressors
Figure 13. Global Transthyretin (TTR) Modulators Sales Market Share by Type in 2026
Figure 14. Global Transthyretin (TTR) Modulators Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Oral TTR Modulators
Figure 16. Product Picture of Subcutaneous/Intravenous TTR Modulators
Figure 17. Global Transthyretin (TTR) Modulators Sales Market Share by Administration in 2026
Figure 18. Global Transthyretin (TTR) Modulators Revenue Market Share by Administration (2021-2026)
Figure 19. Transthyretin (TTR) Modulators Consumed in ATTR-CM
Figure 20. Global Transthyretin (TTR) Modulators Market: ATTR-CM (2021-2026) & (K Units)
Figure 21. Transthyretin (TTR) Modulators Consumed in hATTR-PN
Figure 22. Global Transthyretin (TTR) Modulators Market: hATTR-PN (2021-2026) & (K Units)
Figure 23. Global Transthyretin (TTR) Modulators Sale Market Share by Application (2025)
Figure 24. Global Transthyretin (TTR) Modulators Revenue Market Share by Application in 2025
Figure 25. Transthyretin (TTR) Modulators Sales by Company in 2025 (K Units)
Figure 26. Global Transthyretin (TTR) Modulators Sales Market Share by Company in 2025
Figure 27. Transthyretin (TTR) Modulators Revenue by Company in 2025 ($ millions)
Figure 28. Global Transthyretin (TTR) Modulators Revenue Market Share by Company in 2025
Figure 29. Global Transthyretin (TTR) Modulators Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Transthyretin (TTR) Modulators Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Transthyretin (TTR) Modulators Sales 2021-2026 (K Units)
Figure 32. Americas Transthyretin (TTR) Modulators Revenue 2021-2026 ($ millions)
Figure 33. APAC Transthyretin (TTR) Modulators Sales 2021-2026 (K Units)
Figure 34. APAC Transthyretin (TTR) Modulators Revenue 2021-2026 ($ millions)
Figure 35. Europe Transthyretin (TTR) Modulators Sales 2021-2026 (K Units)
Figure 36. Europe Transthyretin (TTR) Modulators Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Transthyretin (TTR) Modulators Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Transthyretin (TTR) Modulators Revenue 2021-2026 ($ millions)
Figure 39. Americas Transthyretin (TTR) Modulators Sales Market Share by Country in 2025
Figure 40. Americas Transthyretin (TTR) Modulators Revenue Market Share by Country (2021-2026)
Figure 41. Americas Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Figure 42. Americas Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2026)
Figure 43. United States Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Transthyretin (TTR) Modulators Sales Market Share by Region in 2025
Figure 48. APAC Transthyretin (TTR) Modulators Revenue Market Share by Region (2021-2026)
Figure 49. APAC Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Figure 50. APAC Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2026)
Figure 51. China Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 55. India Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Transthyretin (TTR) Modulators Sales Market Share by Country in 2025
Figure 59. Europe Transthyretin (TTR) Modulators Revenue Market Share by Country (2021-2026)
Figure 60. Europe Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Figure 61. Europe Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2026)
Figure 62. Germany Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 63. France Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Transthyretin (TTR) Modulators Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2026)
Figure 70. Egypt Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Transthyretin (TTR) Modulators Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Transthyretin (TTR) Modulators in 2026
Figure 76. Manufacturing Process Analysis of Transthyretin (TTR) Modulators
Figure 77. Industry Chain Structure of Transthyretin (TTR) Modulators
Figure 78. Channels of Distribution
Figure 79. Global Transthyretin (TTR) Modulators Sales Market Forecast by Region (2027-2032)
Figure 80. Global Transthyretin (TTR) Modulators Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Transthyretin (TTR) Modulators Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Transthyretin (TTR) Modulators Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Transthyretin (TTR) Modulators Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Transthyretin (TTR) Modulators Revenue Market Share Forecast by Application (2027-2032)
